Acetaminophen for walking fatigue in multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests whether acetaminophen (the medicine in Tylenol) can help reduce fatigue when walking for people with multiple sclerosis. If you can walk for 2 minutes and have had normal liver and kidney tests recently, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of multiple sclerosis (MS).
- You are between 18 and 65 years old.
- You can walk continuously for 2 minutes, with or without a walking aid.
- You have had a blood test in the last 6 months to 1 year showing normal liver and kidney function.
- You have not had an MS relapse or used steroids recently, and you have no other condition that affects walking besides MS.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a specific type of leg exercise (called eccentric exercise) can help reduce fatigue in people with Multiple Sclerosis. It involves walking and other exercises to see if they improve how tired you feel.
This study tests whether N-acetyl cysteine (a supplement-like medicine) changes body and brain function in people with multiple sclerosis. It may help researchers understand how it affects brain chemistry and activity using special brain imaging.
This study looks at how walking fatigue and the way you walk relate to falls in people with relapsing-remitting multiple sclerosis. It aims to help understand and possibly prevent falls.
This study tests whether TENS, a non-drug device that delivers mild electrical signals through the skin, can reduce fatigue in people with relapsing-remitting multiple sclerosis (MS). It also includes an exercise-training portion and checks safety and comfort during the program.
This trial tests whether adding dalfampridine to physical therapy helps people with multiple sclerosis walk better. You must not already be taking dalfampridine or getting physical therapy to join.
This study tests whether solriamfetol, a medication that promotes wakefulness, can reduce fatigue in people with multiple sclerosis. If you struggle with tiredness and sleepiness, this trial may help you understand how this drug works for MS-related fatigue.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.